Satmat Pharma Private Limited
About Satmat Pharma Private Limited
Data last updated:
Satmat Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It was incorporated on 26 June 2023.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U46497PN2023PTC221665.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Balasaheb Khandu Sangle and Rohit Sampat Ugale.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pune, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.91 Lakh. For the same year it recorded a net profit of ₹7,572 (net margin 1.1%) and EBITDA of ₹8,736 (EBITDA margin 1.3%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No Ug – 27 U G S No 20, East Court Viman Nagar, Pune, Maharashtra, India – 411014
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Satmat Pharma Private Limited
The main business activity of Satmat Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Satmat Pharma Private Limited FY 2025 filings available
Satmat Pharma Private Limited reported revenue of ₹6.91 Lakh for FY 2024.
Financial Statement Summary of Satmat Pharma Private Limited
| Metrics | FY 2023-24 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | •••• |
| Other Income | •••• |
| Total Revenue | •••• |
| Cost of Materials Consumed | •••• |
| Employee Benefit Expense | •••• |
| Finance Costs | •••• |
| Depreciation and Amortisation | •••• |
| Other Expenses | •••• |
| Total Expenses | •••• |
| EBITDA | ₹8,736 |
| Profit Before Tax | •••• |
| Tax Expense | •••• |
| Net Profit (PAT) | ₹7,572 |
| Balance Sheet | |
| Share Capital | •••• |
| Reserves and Surplus | •••• |
| Net Worth (Total Equity) | •••• |
| Long-term Borrowings | •••• |
| Short-term Borrowings | •••• |
| Trade Payables | •••• |
| Total Liabilities | •••• |
| Fixed Assets | •••• |
| Investments | •••• |
| Inventories | •••• |
| Trade Receivables | •••• |
| Cash and Bank Balance | •••• |
| Total Assets | •••• |
Financial Ratios of Satmat Pharma Private Limited
| Metrics | FY 2023-24 |
|---|---|
| Profitability | |
| EBITDA Margin | 1.3% |
| Net Profit Margin | 1.1% |
| Return on Equity (ROE) | •••• |
| Return on Capital Employed (ROCE) | •••• |
| Return on Assets (ROA) | •••• |
| Liquidity and Debt | |
| Current Ratio | •••• |
| Quick Ratio | •••• |
| Debt-to-Equity Ratio | •••• |
| Interest Coverage Ratio | •••• |
| Efficiency and Growth | |
| Asset Turnover | •••• |
| Receivable Days | •••• |
| Payable Days | •••• |
| Inventory Days | •••• |
| Revenue Growth | •••• |
| Net Profit Growth | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Satmat Pharma are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Satmat Pharma Private Limited
Satmat Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Meridian Lifecare Private Limited | ₹6.99 Lakh (FY 2024) | •••• | •••• | -12.0% | •••• | Ambedkar Path Khajpura, Bihar, India |
| Bless Med (India) Private Limited | ₹6.99 Lakh (FY 2025) | •••• | •••• | -85.0% | •••• | Navi Mumbai, Maharashtra, India |
| Admit Pharmaceuticals Private Limited | ₹6.97 Lakh (FY 2024) | •••• | •••• | -14.0% | •••• | Ahmedabad, Gujarat, India |
| Welcure Pharmaceuticals Private Limited | ₹6.93 Lakh (FY 2024) | •••• | •••• | 52.0% | •••• | New Delhi, Delhi, India |
| Puramill Pharmx Private Limited | ₹6.93 Lakh (FY 2023) | •••• | •••• | -85.0% | •••• | Vadodara, Gujarat, India |
| Satmat Pharma Private Limited this company | ₹6.91 Lakh (FY 2024) | •••• | •••• | •••• | Pune, Maharashtra, India | |
| Asdr India Pharmaceuticals Private Limited | ₹6.9 Lakh (FY 2019) | •••• | •••• | -42.0% | •••• | Dehradun, Uttarakhand, India |
| Engee Impex Pvt Ltd | ₹6.88 Lakh (FY 2025) | •••• | •••• | 5.0% | •••• | Kolkata, West Bengal, India |
| Sat Akaal Consultancy Private Limited | ₹6.82 Lakh (FY 2025) | •••• | •••• | -39.0% | •••• | New Delhi, Delhi, India |
| Shiv Hari Pharmaceuticals Private Limited | ₹6.81 Lakh (FY 2025) | •••• | •••• | -88.0% | •••• | Mysore, Karnataka, India |
| Gorelax Pharmaceutical Private Limited | ₹6.8 Lakh (FY 2024) | •••• | •••• | 113.0% | •••• | Ratnagiri, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Satmat Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Satmat Pharma Private Limited
Satmat Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Balasaheb Khandu Sangle | Director | 26 Jun 2023 | 3 Years 3 Months | Current |
| Rohit Sampat Ugale | Director | 26 Jun 2023 | 3 Years 3 Months | Current |
Charges & Borrowings of Satmat Pharma Private Limited
Satmat Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Satmat Pharma Private Limited
Employment history and EPFO contributions of people linked to Satmat Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Satmat Pharma Private Limited
Satmat Pharma Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Balasaheb Khandu Sangle was appointed as Director on 26 Jun 2023.
Credit Ratings, Litigation & Regulatory Alerts for Satmat Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Satmat Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Satmat Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Satmat Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Satmat Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satmat Pharma Private Limited
Satmat Pharma is an active private limited company based in Pune, Maharashtra, India. It was incorporated on 26 June 2023 (3+ years old) and is registered under CIN U46497PN2023PTC221665.
Satmat Pharma reported revenue of ₹6.91 Lakh for FY 2024.
Satmat Pharma has 2 current directors:
- Balasaheb Khandu Sangle - Director
- Rohit Sampat Ugale - Director
Satmat Pharma reported a net profit of ₹7,572 (net margin 1.1%) and EBITDA of ₹8,736 (EBITDA margin 1.3%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Satmat Pharma is U46497PN2023PTC221665. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Satmat Pharma was incorporated on 26 June 2023, making it 3+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Satmat Pharma by revenue are Meridian Lifecare Private Limited, Bless Med (India) Private Limited, Admit Pharmaceuticals Private Limited, Welcure Pharmaceuticals Private Limited, Puramill Pharmx Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Balasaheb Khandu Sangle was appointed as Director on 26 Jun 2023. Rohit Sampat Ugale was appointed as Director on 26 Jun 2023.
The registered office of Satmat Pharma is at Shop No Ug – 27 U G S No 20, East Court Viman Nagar, Pune, Maharashtra, India – 411014.
Satmat Pharma has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh.
No. Satmat Pharma is not listed on any stock exchange. It is an unlisted company.